An open-label study of duloxetine hydrochloride, a mixed serotonin and noradrenaline reuptake inhibitor, in patients with DSM-III-R major depressive disorder

International Clinical Psychopharmacology

Volumn 12, Issue 3, 1997, Pages 137-140

  Berk, M ^a   Du Plessis, A D ^b   Birkett, M ^c   Richardt, D ^a  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b Eli Lilly (SA) (Pty) Ltd   (South Africa)

^c ELI LILLY AND COMPANY   (United States)

Author keywords

Duloxetine hydrochloride; Major depressive disorder; Response; Serotonin and noradrenaline reuptake inhibitor

Indexed keywords

CHLORAL HYDRATE; DULOXETINE; NORADRENALIN UPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TEMAZEPAM;

ADULT; AGITATION; ANXIETY; ARTICLE; CLINICAL TRIAL; CONSTIPATION; DEPRESSION; DIARRHEA; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; FEMALE; HAMILTON SCALE; HEADACHE; HOSPITAL PATIENT; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; ORAL DRUG ADMINISTRATION; OUTPATIENT; PRIORITY JOURNAL; SOMNOLENCE; TREMOR; VERTIGO; XEROSTOMIA;

EID: 0030844643     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004850-199705000-00003     Document Type: Article

References (5)

1. Cleary MA and Guy W (1975) Factor analysis of the Hamilton Depression Scale. Drugs in Experimental Clinical Research, 1, 115-120.
2. Duloxetine HCI (LY248686) An investigational new drug (1994) Clinical Investigation Brochure. Eli Lilly.
3. Katoh A, Eigyo M, Ishibashi C, Naitoh Y, Takeuchi M, Ibii N, Ikeda M and Matsushita A (1995) Behavioral and electroencephalographic properties of duloxetine (LY248686), a reuptake inhibitor of norepinephrine and serotonin, in mice and rats. Journal of Pharmacology and Experimental Therapeutics, 272, 1067-1075.
4. Thor KB and Katofiasc MA (1995) Effects of duloxetine, a combined serotonin and norepinephrine reuptake inhibitor, on central neural control of lower urinary tract function in the ehloralose-anesthetised female cat. Journal of Pharmacology and Experimental Therapeutics, 274, 1014-1024.
5. Wong DT, Bymaster FP, Mayle DA, Reid LR, Krushinski JH and Robertson DW (1993) LY248686, a new inhibitor of serotonin and norepinephrine uptake. Neuropsychopharmacology, 8, 23-33.p